BioLabs builds innovation communities around Biotech entrepreneurs providing them with infrastructure, support, and networking to successfully succeed. Hear how BioLabs has launched 15 sites in the US, Europe and Asia with internationally known strategic partners.
Single-source manufacture of biopharmaceuticals is becoming more and more rare. Increasingly, biomanufacturers or “sponsor” companies partner with contract…
The covid-19 pandemic forced rapid vaccine development and market approval, shortening a process that normally takes years to just a few months. This experience raises a tantalising question: can such speed be sustained for other treatments?
Insights on the changes in the biotech VC landscape and tips from an investor perspective for companies fundraising now.
Check out this article where
Collaboration between biomanufacturers and CDMOs often experiences challenges with data sharing. This presentation highlights the management of heterogenous and asynchronous data and how a data integration platform can improve project lifecycle data management, and collaborative data sharing.
In this webinar, you will:
•Understand the main drivers and benefits of closed processing in biopharma, including facility utilization, sustainability, cost reductions, and labor savings.
•Analyze biopharma facility design, comparing traditional layouts to innovative, modular, and ballroom-style configurations.
•Learn about industry guidance and best practices in the adoption of closed processing.
The definition of Good Laboratory Practice (GLP) is given by the Organization for Economic Co-operation and Development (OECD)…
Understanding regulatory expectations for ancillary/raw materials during development and early clinical phases can be challenging. Join in for a roadmap of current requirements, with a focus on Cell and Gene Therapies.
Vaccine Development collaboration: from Schistosomiasis to COVID-19 vaccine.
